81 related articles for article (PubMed ID: 38559730)
21. Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis and contributes to doxorubicin-induced cardiomyopathy.
Ta N; Qu C; Wu H; Zhang D; Sun T; Li Y; Wang J; Wang X; Tang T; Chen Q; Liu L
Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2117396119. PubMed ID: 36037337
[TBL] [Abstract][Full Text] [Related]
22. The Deficiency of SCARB2/LIMP-2 Impairs Metabolism via Disrupted mTORC1-Dependent Mitochondrial OXPHOS.
Zou Y; Pei J; Wang Y; Chen Q; Sun M; Kang L; Zhang X; Zhang L; Gao X; Lin Z
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955761
[TBL] [Abstract][Full Text] [Related]
23. Bichromophoric ruthenium(II) bis-terpyridine-BODIPY based photosensitizers for cellular imaging and photodynamic therapy.
Paul S; Pathak S; Sahoo S; Maji RC; Bhattacharyya U; Nandi D; Chakravarty AR
Dalton Trans; 2022 Jul; 51(27):10392-10405. PubMed ID: 35758169
[TBL] [Abstract][Full Text] [Related]
24. Intraligand Excited States Turn a Ruthenium Oligothiophene Complex into a Light-Triggered Ubertoxin with Anticancer Effects in Extreme Hypoxia.
Roque Iii JA; Cole HD; Barrett PC; Lifshits LM; Hodges RO; Kim S; Deep G; Francés-Monerris A; Alberto ME; Cameron CG; McFarland SA
J Am Chem Soc; 2022 May; 144(18):8317-8336. PubMed ID: 35482975
[TBL] [Abstract][Full Text] [Related]
25. Asymmetric, amphiphilic RGD conjugated phthalocyanine for targeted photodynamic therapy of triple negative breast cancer.
Li R; Zhou Y; Liu Y; Jiang X; Zeng W; Gong Z; Zheng G; Sun D; Dai Z
Signal Transduct Target Ther; 2022 Feb; 7(1):64. PubMed ID: 35228516
[TBL] [Abstract][Full Text] [Related]
26. Lysosome-targeted ruthenium(II) complexes induce both apoptosis and autophagy in HeLa cells.
Pan NL; Liao JX; Huang MY; Zhang YQ; Chen JX; Zhang ZW; Yang ZX; Long XE; Wu XT; Sun J
J Inorg Biochem; 2022 Apr; 229():111729. PubMed ID: 35066350
[TBL] [Abstract][Full Text] [Related]
27. Lysosome Targeting Bis-terpyridine Ruthenium(II) Complexes: Photophysical Properties and
Liu B; Gao Y; Jabed MA; Kilina S; Liu G; Sun W
ACS Appl Bio Mater; 2020 Sep; 3(9):6025-6038. PubMed ID: 35021831
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic Understanding of Superoxide Radical-Mediated Degradation of Perfluorocarboxylic Acids.
Bai L; Jiang Y; Xia D; Wei Z; Spinney R; Dionysiou DD; Minakata D; Xiao R; Xie HB; Chai L
Environ Sci Technol; 2022 Jan; 56(1):624-633. PubMed ID: 34919383
[TBL] [Abstract][Full Text] [Related]
29. Anticancer Agent with Inexplicable Potency in Extreme Hypoxia: Characterizing a Light-Triggered Ruthenium Ubertoxin.
Cole HD; Roque JA; Shi G; Lifshits LM; Ramasamy E; Barrett PC; Hodges RO; Cameron CG; McFarland SA
J Am Chem Soc; 2022 Jun; 144(22):9543-9547. PubMed ID: 34882381
[TBL] [Abstract][Full Text] [Related]
30. Cationization to boost both type I and type II ROS generation for photodynamic therapy.
Yu Y; Wu S; Zhang L; Xu S; Dai C; Gan S; Xie G; Feng G; Tang BZ
Biomaterials; 2022 Jan; 280():121255. PubMed ID: 34810034
[TBL] [Abstract][Full Text] [Related]
31. Targeting lysosomes in human disease: from basic research to clinical applications.
Cao M; Luo X; Wu K; He X
Signal Transduct Target Ther; 2021 Nov; 6(1):379. PubMed ID: 34744168
[TBL] [Abstract][Full Text] [Related]
32. A highly potent ruthenium(II)-sonosensitizer and sonocatalyst for in vivo sonotherapy.
Liang C; Xie J; Luo S; Huang C; Zhang Q; Huang H; Zhang P
Nat Commun; 2021 Aug; 12(1):5001. PubMed ID: 34408151
[TBL] [Abstract][Full Text] [Related]
33. Ruthenium(II) complexes coordinated to graphitic carbon nitride: Oxygen self-sufficient photosensitizers which produce multiple ROS for photodynamic therapy in hypoxia.
Wei F; Kuang S; Rees TW; Liao X; Liu J; Luo D; Wang J; Zhang X; Ji L; Chao H
Biomaterials; 2021 Sep; 276():121064. PubMed ID: 34391019
[TBL] [Abstract][Full Text] [Related]
34. Clinical Practice of Photodynamic Therapy Using Talaporfin Sodium for Esophageal Cancer.
Yano T; Minamide T; Takashima K; Nakajo K; Kadota T; Yoda Y
J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34202917
[TBL] [Abstract][Full Text] [Related]
35. Lysosome biogenesis: Regulation and functions.
Yang C; Wang X
J Cell Biol; 2021 Jun; 220(6):. PubMed ID: 33950241
[TBL] [Abstract][Full Text] [Related]
36. Red-Light-Responsive Ru Complex Photosensitizer for Lysosome Localization Photodynamic Therapy.
He G; Xu N; Ge H; Lu Y; Wang R; Wang H; Du J; Fan J; Sun W; Peng X
ACS Appl Mater Interfaces; 2021 May; 13(17):19572-19580. PubMed ID: 33900720
[TBL] [Abstract][Full Text] [Related]
37. Targeting Lysosomal Degradation Pathways: New Strategies and Techniques for Drug Discovery.
Pei J; Wang G; Feng L; Zhang J; Jiang T; Sun Q; Ouyang L
J Med Chem; 2021 Apr; 64(7):3493-3507. PubMed ID: 33764774
[TBL] [Abstract][Full Text] [Related]
38. Rational design of a lysosome-targeting and near-infrared absorbing Ru(ii)-BODIPY conjugate for photodynamic therapy.
Qiao L; Liu J; Han Y; Wei F; Liao X; Zhang C; Xie L; Ji L; Chao H
Chem Commun (Camb); 2021 Feb; 57(14):1790-1793. PubMed ID: 33475648
[TBL] [Abstract][Full Text] [Related]
39. Solution structure of the voltage-gated Tim23 channel in complex with a mitochondrial presequence peptide.
Zhou S; Ruan M; Li Y; Yang J; Bai S; Richter C; Schwalbe H; Xie C; Shen B; Wang J
Cell Res; 2021 Jul; 31(7):821-824. PubMed ID: 33318647
[No Abstract] [Full Text] [Related]
40. The role of lysosomes in cancer development and progression.
Tang T; Yang ZY; Wang D; Yang XY; Wang J; Li L; Wen Q; Gao L; Bian XW; Yu SC
Cell Biosci; 2020 Nov; 10(1):131. PubMed ID: 33292489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
